Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 27,999 $ 126 $ 451,150 $ (422,927) $ (350)
Beginning balance (in shares) at Dec. 31, 2022   12,598,641      
Issuance of ordinary shares, net 444 $ 4 440    
Issuance of ordinary shares, net (in shares)   442,400      
Share-based compensation expense 645   645    
Net loss (26,009)     (26,009)  
Unrealized gain on available-for-sale securities 353       353
Ending balance at Sep. 30, 2023 3,432 $ 130 452,235 (448,936) 3
Ending balance (in shares) at Sep. 30, 2023   13,041,041      
Beginning balance at Dec. 31, 2022 27,999 $ 126 451,150 (422,927) (350)
Beginning balance (in shares) at Dec. 31, 2022   12,598,641      
Net loss (38,371)        
Ending balance at Dec. 31, 2023 (6,403) $ 135 454,759 (461,298) 1
Ending balance (in shares) at Dec. 31, 2023   13,499,003      
Beginning balance at Jun. 30, 2023 7,129 $ 130 452,084 (445,059) (26)
Beginning balance (in shares) at Jun. 30, 2023   13,028,403      
Issuance of ordinary shares, net (in shares)   12,638      
Share-based compensation expense 151   151    
Net loss (3,877)     (3,877)  
Unrealized gain on available-for-sale securities 29       29
Ending balance at Sep. 30, 2023 3,432 $ 130 452,235 (448,936) 3
Ending balance (in shares) at Sep. 30, 2023   13,041,041      
Beginning balance at Dec. 31, 2023 (6,403) $ 135 454,759 (461,298) 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Issuance of ordinary shares, net 10,066 $ 92 9,974    
Issuance of ordinary shares, net (in shares)   9,177,847      
Issuance of warrants for ordinary shares, net 2,718   2,718    
Exercise of share options $ 29   29    
Exercise of share options, (in shares) 29,144 29,144      
Share-based compensation expense $ 274   274    
Net loss (18,192)     (18,192)  
Unrealized gain on available-for-sale securities 1       1
Ending balance at Sep. 30, 2024 (11,507) $ 227 467,754 (479,490) 2
Ending balance (in shares) at Sep. 30, 2024   22,705,994      
Beginning balance at Jun. 30, 2024 (10,913) $ 166 462,318 (473,396) (1)
Beginning balance (in shares) at Jun. 30, 2024   16,584,029      
Issuance of ordinary shares, net 2,712 $ 61 2,651    
Issuance of ordinary shares, net (in shares)   6,121,965      
Issuance of warrants for ordinary shares, net 2,718   2,718    
Share-based compensation expense 67   67    
Net loss (6,094)     (6,094)  
Unrealized gain on available-for-sale securities 3       3
Ending balance at Sep. 30, 2024 $ (11,507) $ 227 $ 467,754 $ (479,490) $ 2
Ending balance (in shares) at Sep. 30, 2024   22,705,994